IS PINDOLOL A MIXED AGONIST-ANTAGONIST AT CENTRAL SEROTONIN (5-HT) RECEPTORS

[31] BETA-ADRENOCEPTOR ANTAGONISTS IN PSYCHIATRY AND NEUROLOGY [J]. PHARMACOLOGY & THERAPEUTICS, 1981, 12 (02) : 419 - 437

[32] DIFFERENT STERIC CHARACTERISTICS OF BETA-1-ADRENOCEPTOR AND BETA-2-ADRENOCEPTORS [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 327 (02) : 176 - 179

[33] NAHORSKI SR, 1983, BRIT J PHARMACOL, V78, pP107

[34] STUDIES ON THE MECHANISMS BY WHICH CLENBUTEROL, A BETA-ADRENOCEPTOR AGONIST, ENHANCES 5-HT-MEDIATED BEHAVIOR AND INCREASES METABOLISM OF 5-HT IN THE BRAIN OF THE RAT [J]. NEUROPHARMACOLOGY, 1983, 22 (06) : 739 - 749

[35] CENTRAL ACTIONS OF BETA-ADRENOCEPTOR BLOCKING-DRUGS IN MAN [J]. MEDICINAL RESEARCH REVIEWS, 1981, 1 (04) : 387 - 410

[36] EFFECT OF BETA-ADRENOCEPTOR BLOCKING-DRUGS ON EEG [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (04) : 661 - 665

[37] SANER A, J PHARM PHARM, V30, P115

[38] SIMULTANEOUS MEASUREMENT OF 5-HYDROXYTRYPTOPHAN AND L-DIHYDROXYPHENYLALANINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION - MEASUREMENT OF SEROTONIN AND CATECHOLAMINE TURNOVER IN DISCRETE BRAIN-REGIONS [J]. JOURNAL OF CHROMATOGRAPHY, 1982, 228 (MAR): : 123 - 130

[39] SVENSSON K, 1986, THESIS U GOTEBORG

[40] THE INVOLVEMENT OF SUBTYPES OF THE 5-HT1 RECEPTOR AND OF CATECHOLAMINERGIC SYSTEMS IN THE BEHAVIORAL-RESPONSE TO 8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN IN THE RAT [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 106 (02) : 271 - 282

[31] BETA-ADRENOCEPTOR ANTAGONISTS IN PSYCHIATRY AND NEUROLOGY [J]. PHARMACOLOGY & THERAPEUTICS, 1981, 12 (02) : 419 - 437

[32] DIFFERENT STERIC CHARACTERISTICS OF BETA-1-ADRENOCEPTOR AND BETA-2-ADRENOCEPTORS [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 327 (02) : 176 - 179

[33] NAHORSKI SR, 1983, BRIT J PHARMACOL, V78, pP107

[34] STUDIES ON THE MECHANISMS BY WHICH CLENBUTEROL, A BETA-ADRENOCEPTOR AGONIST, ENHANCES 5-HT-MEDIATED BEHAVIOR AND INCREASES METABOLISM OF 5-HT IN THE BRAIN OF THE RAT [J]. NEUROPHARMACOLOGY, 1983, 22 (06) : 739 - 749

[35] CENTRAL ACTIONS OF BETA-ADRENOCEPTOR BLOCKING-DRUGS IN MAN [J]. MEDICINAL RESEARCH REVIEWS, 1981, 1 (04) : 387 - 410

[36] EFFECT OF BETA-ADRENOCEPTOR BLOCKING-DRUGS ON EEG [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (04) : 661 - 665

[37] SANER A, J PHARM PHARM, V30, P115

[38] SIMULTANEOUS MEASUREMENT OF 5-HYDROXYTRYPTOPHAN AND L-DIHYDROXYPHENYLALANINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION - MEASUREMENT OF SEROTONIN AND CATECHOLAMINE TURNOVER IN DISCRETE BRAIN-REGIONS [J]. JOURNAL OF CHROMATOGRAPHY, 1982, 228 (MAR): : 123 - 130

[39] SVENSSON K, 1986, THESIS U GOTEBORG

[40] THE INVOLVEMENT OF SUBTYPES OF THE 5-HT1 RECEPTOR AND OF CATECHOLAMINERGIC SYSTEMS IN THE BEHAVIORAL-RESPONSE TO 8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN IN THE RAT [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 106 (02) : 271 - 282